Basic info
Industry
pharmaceuticals
Sectors
Relapsed & Relapsed-Refractory Multiple Myeloma
melflufen
Multiple Myeloma
peptide conjugated alkylator
peptidase targeting
anti-angiogenic
Peptidase Enhanced Cytotoxics
Orphan Drug
cytotoxicity
oncology
phase 3
phase 1
Plasma Cell Myeloma
RRMM
PEnC
efficacy studies
alkylation
Ygalo
Date founded
2000